Abstracto

The Impact of Monoclonal Antibodies on Public Health and Healthcare Delivery

Ifedayo Yanronii

Monoclonal antibodies (mAbs) have become an important tool in the treatment of many diseases, including cancer and autoimmune disorders. In recent years, the use of mAbs has expanded to include the treatment of infectious diseases, such as COVID-19. The impact of mAbs on public health and healthcare delivery has been significant and their use is likely to continue to grow in the coming years.